Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 14/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10167883 | 0.97 | APP (0.93) | APPCYP1A2EGFRTLR7 | |
| SCHEMBL10167880 | 0.92 | APP (1.00) | APPCYP1A2TLR7 | |
| SCHEMBL31115697 | 0.89 | APP (1.00) | APPCYP1A2EGFRNPC1RAB9A | |
| SCHEMBL563392 | 0.89 | APP (1.00) | APPCYP1A2EGFRNPC1RAB9A | |
| SCHEMBL1104921 | 0.88 | APP (1.00) | APPCYP1A2EGFRNPC1RAB9A | |
| SCHEMBL10167881 | 0.88 | APP (1.00) | APPCYP1A2TLR7 | |
| SCHEMBL16069679 | 0.88 | APP (0.81) | APPCYP1A2TLR7 | |
| SCHEMBL31492097 | 0.86 | APP (0.78) | APPCYP1A2 | |
| SCHEMBL505449 | 0.86 | APP (0.78) | APPCYP1A2 | |
| SCHEMBL1104925 | 0.85 | APP (0.80) | APPCYP1A2EGFRTLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9216974-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2015-12-22 | — | — | US | disclosed |
| US-9216974-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2015-12-22 | — | — | US | disclosed |
| US-9115099-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2015-08-25 | — | — | US | disclosed |
| US-9115099-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20150175589-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | UNIV WASHINGTON (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150175589-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | UNIV WASHINGTON (US) | 2015-06-25 | — | — | US | disclosed |
| US-20140221647-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | WASHINGTON UNIVERSITY | 2014-08-07 | — | — | US | disclosed |
| US-20140221647-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | WASHINGTON UNIVERSITY | 2014-08-07 | — | — | US | disclosed |
| US-8735575-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2014-05-27 | — | — | US | disclosed |
| US-8735575-B2 | Phenoxazine derivatives and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2014-05-27 | — | — | US | disclosed |
| US-20120035359-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | THE WASHINGTON UNIVERSITY (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035359-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | THE WASHINGTON UNIVERSITY (US) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221647-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | PPOX, CYP4Z1, PRDX2 | APP 3242/4885CYP1A2 12/4885EGFR 3873/4885 |
| US-20150175589-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | PPOX, CYP4Z1, PRDX2 | APP 3242/4885CYP1A2 12/4885EGFR 3873/4885 |
| US-20120035359-A1 | PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF | PPOX, CYP4Z1, PRDX2 | APP 3242/4885CYP1A2 12/4885EGFR 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.